Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncertain because of a lack of an underlying hypothesis to explain why antiphospholipid autoantibodies (aPL) form to such ubiquitous compounds as phospholipids (PL). In this paper, we demonstrate that many,...
-д хадгалсан:
| -д хэвлэсэн: | J Clin Invest |
|---|---|
| Үндсэн зохиолчид: | , , , , , , , , , , |
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
American Society for Clinical Investigation
1996
|
| Нөхцлүүд: | |
| Онлайн хандалт: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507492/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8698874/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118854 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
